nlm_download_date_description,study_first_submitted_date,results_first_submitted_date,disposition_first_submitted_date,last_update_submitted_date,study_first_submitted_qc_date,study_first_posted_date,study_first_posted_date_type,results_first_submitted_qc_date,results_first_posted_date,results_first_posted_date_type,disposition_first_submitted_qc_date,disposition_first_posted_date,disposition_first_posted_date_type,last_update_submitted_qc_date,last_update_posted_date,last_update_posted_date_type,start_month_year,start_date_type,start_date,verification_month_year,verification_date,completion_month_year,completion_date_type,completion_date,primary_completion_month_year,primary_completion_date_type,primary_completion_date,target_duration,study_type,acronym,baseline_population,brief_title,official_title,overall_status,last_known_status,phase,enrollment,enrollment_type,source,limitations_and_caveats,number_of_arms,number_of_groups,why_stopped,has_expanded_access,expanded_access_type_individual,expanded_access_type_intermediate,expanded_access_type_treatment,has_dmc,is_fda_regulated_drug,is_fda_regulated_device,is_unapproved_device,is_ppsd,is_us_export,biospec_retention,biospec_description,ipd_time_frame,ipd_access_criteria,ipd_url,plan_to_share_ipd,plan_to_share_ipd_description,created_at,updated_at,id,nct_id,mesh_term,downcase_mesh_term,intervention_type,intervention_name,description,intervention_count,status,facility_name,city,state,zip,country,site_count
"ClinicalTrials.gov processed this data on April 17, 2020",2020-04-07,NA,NA,2020-04-07,2020-04-07,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-04-07,2020-04-10,Actual,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,August 2020,Anticipated,2020-08-31,August 2020,Anticipated,2020-08-31,NA,Observational,BIOCOVU,,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient Admitted to Emergency Departments During an Epidemic,Not yet recruiting,NA,NA,1000,Anticipated,"University Hospital, Lille",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-20T08:49:51Z,2020-04-20T08:49:51Z,5057349,NCT04341792,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 17, 2020",2020-04-07,NA,NA,2020-04-07,2020-04-07,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-04-07,2020-04-10,Actual,"April 9, 2020",Anticipated,2020-04-09,April 2020,2020-04-30,"December 31, 2021",Anticipated,2021-12-31,"November 30, 2020",Anticipated,2020-11-30,NA,Observational,BURDENCOV,,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers","""Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers"" ""Impact Psychologique de l'Ã©pidÃ©mie COVID-19 Chez Les Patients, Familles et Soignants de Reanimation"" ""BURDENCOV""",Not yet recruiting,NA,NA,1464,Anticipated,Assistance Publique - HÃ´pitaux de Paris,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-20T08:50:00Z,2020-04-20T08:50:00Z,5057385,NCT04341519,Coronavirus Infections,coronavirus infections,Behavioral|Behavioral,PTSD|Burnout,"family members: post-traumatic stress disorder (PTSD) related symptoms assessed by Impact of Event Scale Revised (IES-R) at 90 days
Patients:
post-traumatic stress disorder (PTSD) related symptoms assessed by Impact of Event Scale Revised (IES-R) at 90 days|Symptoms of burnout as assessed by the Maslash Burnout Inventory",2,,Saint-Louis Hospital,Paris,Ile De France,75010,France,1
"ClinicalTrials.gov processed this data on April 17, 2020",2020-03-26,NA,NA,2020-04-09,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-10,Actual,"March 20, 2020",Actual,2020-03-20,April 2020,2020-04-30,"September 1, 2020",Anticipated,2020-09-01,"July 1, 2020",Anticipated,2020-07-01,NA,Observational,NA,,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,"Proflaxis for Healthcare Professionals Using Hydroxychloroquine Plus Vitamin Combining Vitamins C, D and Zinc During COVID-19 Pandemia: An Observational Study",Recruiting,NA,NA,80,Anticipated,Istinye University,,NA,1,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-04-20T08:51:32Z,2020-04-20T08:51:32Z,5057678,NCT04326725,Coronavirus Infections,coronavirus infections,Drug,Plaquenil 200Mg Tablet,health workers under risk who took this medications,1,Recruiting,Istinye University Medical School,Istanbul,,34010,Turkey,1
"ClinicalTrials.gov processed this data on April 17, 2020",2020-03-26,NA,NA,2020-04-09,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-10,Actual,"April 6, 2020",Actual,2020-04-06,April 2020,2020-04-30,"October 7, 2021",Anticipated,2021-10-07,"April 7, 2021",Anticipated,2021-04-07,NA,Observational,COVIDx,,Evaluation of Novel Diagnostic Tests for COVID-19,Evaluation of Novel Diagnostic Tests for 2019-nCOV,Recruiting,NA,NA,200,Anticipated,Cambridge University Hospitals NHS Foundation Trust,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Throat/Nasal Swab, Nasopharyngeal Swab, Endotracheal tube aspirate and whole blood-serum for
      viral-RNA analysis
    ",NA,NA,NA,Undecided,NA,2020-04-20T08:51:32Z,2020-04-20T08:51:32Z,5057681,NCT04326387,Coronavirus Infections,coronavirus infections,Diagnostic Test|Diagnostic Test|Diagnostic Test|Diagnostic Test,SAMBA II (Diagnostic for the Real World)|Public Health England Gold Standard|Cambridge Validated Viral Detection Method|Radiological Detection,Point of care Isothermal-PCR Viral RNA Amplication for virus detection|Reverse Transcription PCR|Reverse Transcription PCR|Chest X-ray & CT Scan detection of viral infection in the lungs,4,Recruiting,Cambridge University Hospitals NHS Foundation Trust,Cambridge,Cambridgeshire,CB2 0QQ,United Kingdom,1
"ClinicalTrials.gov processed this data on April 17, 2020",2020-01-26,NA,NA,2020-04-09,2020-01-26,2020-01-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-10,Actual,"January 1, 2020",Actual,2020-01-01,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"December 31, 2020",Anticipated,2020-12-31,NA,Observational,NA,,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV","Development of a Simple, Fast and Portable Recombinase Aided Amplification (RAA) Assay for 2019-nCoV",Recruiting,NA,NA,50,Anticipated,Beijing Ditan Hospital,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-20T08:53:29Z,2020-04-20T08:53:29Z,5058192,NCT04245631,Coronavirus Infections,coronavirus infections,Diagnostic Test,Recombinase aided amplification (RAA) assay,"We established a real time reverse-transcription RAA (RT-RAA) assay for detection of 2019-nCoV. This assay was performed at 42Â°C within 30min using a portable real-time fluorescence detector, Recombinant plasmids containing conserved ORF1ab genes was used to analyze the specificity and sensitivity. Clinical specimens from patients who were suspected of being infected with 2019-nCoV were used to evaluate the performance of the assay. In parallel, we also used the commercial RT-qPCR assay kit for 2019-nCoV as a reference. Sample types include either of nasal swab, oral swab, bronchoalveolar-lavage fluid, urea, blood, fecal.",1,Recruiting,"Department of Hepatology Division 2, Beijing Ditan Hospital",Beijing,Beijing,100015,China,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-17,NA,NA,2020-03-17,2020-03-17,2020-03-19,Actual,NA,NA,NA,NA,NA,NA,2020-03-17,2020-03-19,Actual,"March 23, 2020",Anticipated,2020-03-23,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"December 31, 2021",Anticipated,2021-12-31,NA,Observational,COVID MECH,,Mechanisms to Morbidity and Mortality for Covid-19,"Changes in Organ Specific Biomarkers, Virus Expression and Prognosis for Covid-19",Not yet recruiting,NA,NA,200,Anticipated,"University Hospital, Akershus",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:19:19Z,2020-04-01T09:19:19Z,4274145,NCT04314232,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-06,NA,NA,2020-02-07,2020-02-07,2020-02-10,Actual,NA,NA,NA,NA,NA,NA,2020-02-07,2020-02-11,Actual,"February 7, 2020",Actual,2020-02-07,February 2020,2020-02-29,"August 7, 2023",Anticipated,2023-08-07,"August 7, 2020",Anticipated,2020-08-07,NA,Observational,CCP-nCoV,,Clinical Characterisation Protocol for Severe Emerging Infections,Clinical Characterisation Protocol for Severe Emerging Infections,Recruiting,NA,NA,500,Anticipated,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood, urine, stool /rectal swab, respiratory samples (nose and throat swab, endotracheal
      aspirate, nasopharyngeal aspirate), samples from infected sites/sores, CSF
    ",NA,NA,NA,Undecided,NA,2020-04-01T09:25:58Z,2020-04-01T09:25:58Z,4280580,NCT04262921,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting|Recruiting|Recruiting|Recruiting,"CHU Pellegrin, service des Maladies Infectieuses et Tropicales|APHP La PitiÃ© SalpÃªtriÃ¨re, service des Maladies Infectieuses et Tropicales|APHP Bichat, Service de rÃ©animation mÃ©dicale et infectieuse|APHP Bichat, Service des Maladies Infectieuses et Tropicales",Bordeaux|Paris|Paris|Paris,|||,33075|75013|75018|75018,France|France|France|France,4
"ClinicalTrials.gov processed this data on April 09, 2020",2020-03-24,NA,NA,2020-03-28,2020-03-25,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-28,2020-03-31,Actual,"March 19, 2020",Actual,2020-03-19,March 2020,2020-03-31,"May 19, 2020",Anticipated,2020-05-19,"May 19, 2020",Anticipated,2020-05-19,NA,Observational,SISCO,,An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection,An Observational Case-control Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,Recruiting,NA,NA,50,Anticipated,A.O. Ospedale Papa Giovanni XXIII,,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-10T09:16:44Z,2020-04-10T09:16:44Z,4940219,NCT04322188,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,ASST - Papa Giovanni XXIII,Bergamo,,24127,Italy,1
"ClinicalTrials.gov processed this data on April 09, 2020",2020-03-23,NA,NA,2020-03-27,2020-03-23,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-27,2020-03-31,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,"March 20, 2030",Anticipated,2030-03-20,"March 27, 2022",Anticipated,2022-03-27,NA,Observational,NA,,Risk Factors for Community- and Workplace Transmission of COVID-19,Risk Factors for Community- and Workplace Transmission of COVID-19,Recruiting,NA,NA,50000,Anticipated,Oslo University Hospital,,NA,5,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood and upper repiratory samples will be collected from some participants.
    ",NA,NA,NA,No,"European GDPR regulations severely limits IPD, but the study will share data to the largest extent possible within GDPR.",2020-04-10T09:16:51Z,2020-04-10T09:16:51Z,4940261,NCT04320732,Coronavirus Infections,coronavirus infections,Behavioral,Observation of behavior and COVID-19 infection will be conducted.,"No intervention, only prospective observation of behavior will be conducted by a questionnaire.",1,Recruiting,Oslo University Hospital,Oslo,,0424,Norway,1
"ClinicalTrials.gov processed this data on April 09, 2020",2020-03-27,NA,NA,2020-03-30,2020-03-30,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"January 30, 2020",Actual,2020-01-30,March 2020,2020-03-31,"April 15, 2020",Anticipated,2020-04-15,"April 2, 2020",Anticipated,2020-04-02,NA,Observational,NA,,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 in Chibi Hospital of Hubei Province,Recruiting,NA,NA,120,Anticipated,Shanghai 10th People's Hospital,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-10T09:15:14Z,2020-04-10T09:15:14Z,4939855,NCT04328454,Coronavirus Infections,coronavirus infections,Other,retrospective analysis,The investigators retrospectively analyzed the hospitalized patients with COVID-19,1,Recruiting,Shanghai 10th People's Hospital,Shanghai,Shanghai,+86200072,China,1
"ClinicalTrials.gov processed this data on April 22, 2020",2020-03-26,NA,NA,2020-04-10,2020-03-26,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"March 25, 2020",Actual,2020-03-25,April 2020,2020-04-30,"April 10, 2020",Anticipated,2020-04-10,"April 3, 2020",Anticipated,2020-04-03,NA,Observational,NA,,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Recruiting,NA,NA,120,Anticipated,UnitedHealth Group,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Patients will return at the following times to complete the same battery of sample
      collection:

        -  7-9 days after initially testing positive;

        -  14-18 days after initially testing positive;

        -  28-42 days after initially testing positive. Additional visits, during which additional
           samples could be collected may occur after 42 days if agreeable to the participants and
           desired by the study investigators.
    ",2 months,"The data collected due to this study will be extracted from the medical record and stored for additional research analysis to demonstrate equivalence between location in the two nasal swabs. Blood samples will be delivered to PATH and the Mayo Clinic for storage and analysis. Patients may not have access to these samples or the blood features derived from them after sample collection. Data will be shared between the participating clinics, UHG and collaborating partners performing the analysis of the samples and returning results.",NA,Yes,"Four data sources will be recorded for each patient who consents to participate in the study:
Electronic medical record (EMR);
Results of testing from the foam and polyester nasal swab samples;
Results of any blood testing performed on the blood samples;
Responses to a set of standard questions posed to each participant.",2020-04-24T09:08:15Z,2020-04-24T09:08:15Z,5099425,NCT04327804,Coronavirus Infections,coronavirus infections,Diagnostic Test,Odd/Even birth year intervention groups,The nostril used and order of testing will be different in each arm.,1,Recruiting,Everett Clinic,Seattle,Washington,98133,United States,1
"ClinicalTrials.gov processed this data on April 22, 2020",2020-03-25,NA,NA,2020-04-10,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"March 10, 2020",Actual,2020-03-10,April 2020,2020-04-30,"May 8, 2020",Anticipated,2020-05-08,"April 10, 2020",Anticipated,2020-04-10,NA,Observational,CORONADO,,"""COVID-19 and Diabetes Outcomes""","""Coronavirus SARS-CoV2 and Diabetes Outcomes"" : CORONADO",Recruiting,NA,NA,1000,Anticipated,Nantes University Hospital,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-24T09:08:24Z,2020-04-24T09:08:24Z,5099458,NCT04324736,Coronavirus Infections,coronavirus infections,Other,no interventional study,no interventional study,1,Recruiting,CHU Nantes,Nantes,,44000,France,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-08,NA,NA,2020-03-16,2020-03-11,2020-03-12,Actual,NA,NA,NA,NA,NA,NA,2020-03-16,2020-03-17,Actual,"March 8, 2020",Actual,2020-03-08,March 2020,2020-03-31,"May 31, 2020",Anticipated,2020-05-31,"May 31, 2020",Anticipated,2020-05-31,NA,Observational,NA,,Social Media Use During COVID-19,Getting it Right: Towards Responsible Social Media Use During a Pandemic,Recruiting,NA,NA,5000,Anticipated,Yale-NUS College,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,"Due to stipulations by the Institutional Review Board, data cannot be shared.",2020-04-01T09:20:25Z,2020-04-01T09:20:25Z,4275274,NCT04305574,Coronavirus Infections,coronavirus infections,Behavioral,Use of social media during COVID-19,Participants' self-reported use of social media to receive and share news about COVID-19,1,Recruiting,Yale-NUS College,Singapore,,138527,Singapore,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-10,NA,NA,2020-03-14,2020-03-10,2020-03-13,Actual,NA,NA,NA,NA,NA,NA,2020-03-14,2020-03-17,Actual,"March 19, 2020",Anticipated,2020-03-19,March 2020,2020-03-31,"December 31, 2020",Anticipated,2020-12-31,"April 19, 2020",Anticipated,2020-04-19,NA,Observational,NA,,Acute Respiratory Failure and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Real Life,Acute Respiratory Failure and Continuous Positive Airway Pressure Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: a Real Life Evaluation,Not yet recruiting,NA,NA,50,Anticipated,University of Milan,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-01T09:20:12Z,2020-04-01T09:20:12Z,4275055,NCT04307459,Coronavirus Infections,coronavirus infections,Other,standard operating procedures,"standard operating procedures represented by continuous positive airway pressure (CPAP) therapy or non invasive ventilation, pharmacological treatment as antiviral and antibiotic drugs, bronchodilators, xanthines, enteral nutrition, hydration.",1,,Luigi Sacco University Hospital,Milan,Lombardia,20157,Italy,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-25,NA,NA,2020-02-28,2020-02-28,2020-03-03,Actual,NA,NA,NA,NA,NA,NA,2020-02-28,2020-03-03,Actual,"February 1, 2020",Actual,2020-02-01,February 2020,2020-02-29,"December 31, 2020",Anticipated,2020-12-31,"July 31, 2020",Anticipated,2020-07-31,NA,Observational,NA,,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,The Efficacy and Safety of Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of Novel Coronavirus Pneumonia Patient (COVID-19) : An Observational Study,Recruiting,NA,NA,15,Anticipated,Shanghai Public Health Clinical Center,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:22:05Z,2020-04-01T09:22:05Z,4276857,NCT04292340,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Shanghai Public Health Clinical Center,Shanghai,Shanghai,201508,China,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-23,NA,NA,2020-02-29,2020-02-29,2020-03-03,Actual,NA,NA,NA,NA,NA,NA,2020-02-29,2020-03-03,Actual,"January 1, 2020",Actual,2020-01-01,February 2020,2020-02-29,"July 31, 2020",Anticipated,2020-07-31,"April 30, 2020",Anticipated,2020-04-30,NA,Observational,2019-nCoV,,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus(2019-nCoV),"Active, not recruiting",NA,NA,400,Anticipated,Fujian Provincial Hospital,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-01T09:22:05Z,2020-04-01T09:22:05Z,4276858,NCT04292327,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,,Fujian Provincial Hospital,Fuzhou,Fujian,350000,China,1
"ClinicalTrials.gov processed this data on April 24, 2020",2020-04-09,NA,NA,2020-04-15,2020-04-10,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-04-15,2020-04-16,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"June 1, 2022",Anticipated,2022-06-01,"April 15, 2020",Anticipated,2020-04-15,NA,Observational,STOP-COVID,,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Recruiting,NA,NA,2000,Anticipated,Brigham and Women's Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-26T09:06:09Z,2020-04-26T09:06:09Z,5123689,NCT04343898,Coronavirus Infections,coronavirus infections,Other,No intervention,Observational,1,Recruiting,Brigham and Women's Hospital,Boston,Massachusetts,02115,United States,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-19,NA,NA,2020-02-19,2020-02-19,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-02-19,2020-02-21,Actual,"January 20, 2020",Actual,2020-01-20,February 2020,2020-02-29,"February 28, 2021",Anticipated,2021-02-28,"January 31, 2021",Anticipated,2021-01-31,NA,Observational,NA,,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Study on Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations in Patients,Recruiting,NA,NA,20,Anticipated,"Third Affiliated Hospital, Sun Yat-Sen University",,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-01T09:23:39Z,2020-04-01T09:23:39Z,4278532,NCT04279795,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,510630,China,1
"ClinicalTrials.gov processed this data on April 10, 2020",2020-03-30,NA,NA,2020-03-31,2020-03-31,2020-04-01,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-01,Actual,April 2020,Anticipated,2020-04-30,March 2020,2020-03-31,May 2022,Anticipated,2022-05-31,May 2022,Anticipated,2022-05-31,NA,Observational,NA,,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Not yet recruiting,NA,NA,50,Anticipated,Stanford University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-11T09:12:30Z,2020-04-11T09:12:30Z,4953200,NCT04330521,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 16, 2020",2020-04-06,NA,NA,2020-04-06,2020-04-06,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-07,Actual,"December 23, 2019",Actual,2019-12-23,March 2020,2020-03-31,"March 3, 2020",Actual,2020-03-03,"January 20, 2020",Actual,2020-01-20,NA,Observational,NA,,Clinical and Radiomic Model of COVID-19,A Clinical and Radiological Model to Predict the Prognosis for COVID-19 Patients,Completed,NA,NA,300,Actual,Maastricht University,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,No share plan,2020-04-17T09:12:02Z,2020-04-17T09:12:02Z,5023014,NCT04337502,Coronavirus Infections,coronavirus infections,Diagnostic Test,Machine learning model,"Machine learning, such as logistic regression, random forest, and deep learning",1,,The central hospital of Wuhan,Wuhan,Hubei,,China,1
"ClinicalTrials.gov processed this data on April 16, 2020",2020-04-01,NA,NA,2020-04-06,2020-04-06,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-07,Actual,"April 1, 2020",Anticipated,2020-04-01,April 2020,2020-04-30,"April 1, 2021",Anticipated,2021-04-01,"April 1, 2021",Anticipated,2021-04-01,NA,Observational,REMOTE-COVID,,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),REmote MOniToring usE in Suspected Cases of COVID-19 (Coronavirus): REMOTE-COVID Trial,Not yet recruiting,NA,NA,200,Anticipated,Imperial College London,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-17T09:12:02Z,2020-04-17T09:12:02Z,5023015,NCT04337489,Coronavirus Infections,coronavirus infections,Device,SensiumVitals wearable sensor,"A waterproof, light, wearable sensor measuring vital signs (heart rate, respiratory rate, temperature) continuously.",1,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 10, 2020",2020-03-26,NA,NA,2020-03-30,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-01,Actual,"March 23, 2020",Actual,2020-03-23,March 2020,2020-03-31,"September 20, 2020",Anticipated,2020-09-20,"July 20, 2020",Anticipated,2020-07-20,NA,Observational,NA,,Active Monitoring And Determinants of Incidence Infection of COVDI-19,Active Monitoring And Determinants of Incidence Infection of COVDI-19 in a Hospital Population (AMADIICH) Study Protocol,Recruiting,NA,NA,1000,Anticipated,"FundaciÃ³n TeÃ³filo Hernando, Spain",,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-11T09:13:56Z,2020-04-11T09:13:56Z,4953508,NCT04326400,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Hospital Universitario de la Princesa,Madrid,,28006,Spain,1
"ClinicalTrials.gov processed this data on April 09, 2020",2020-03-19,NA,NA,2020-03-30,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"March 19, 2020",Actual,2020-03-19,March 2020,2020-03-31,"March 19, 2022",Anticipated,2022-03-19,"March 19, 2022",Anticipated,2022-03-19,NA,Observational,COVID-BioB,,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor","Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response",Recruiting,NA,NA,1000,Anticipated,UniversitÃ  Vita-Salute San Raffaele,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-10T09:17:06Z,2020-04-10T09:17:06Z,4940288,NCT04318366,Coronavirus Infections,coronavirus infections,Other,Observational Study,Not required,1,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,"Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute|AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute|Department of Infection Diseases - IRCCS San Raffaele Scientific Institute -|Department of Internal Medicine - IRCCS San Raffaele Scientific Institute|Diabetes Research Institute -IRCCS San Raffaele Scientific Istitute|Division of Immunology, Transplantation and Infectious Diseases - IRCCS San Raffaele Scientific Institute|Division of Research of Regenerative Medicine, Cell and Gene Therapy - IRCCS San Raffaele Scientific Istitute|Laboratory of Microbiology and Virology - IRCCS San Raffaele Scientific Institute|Nephrology Unit - IRCCS San Raffaele Scientific Institute|Strategic Program in Nephrology and Dialysis - IRCCS San Raffaele Scientific Institute|Viral pathogens and biosafety Unit - IRCCS San Raffaele Scietific Institute|Unit of Immunology, Rheumatology, Allergy and Rare Diseases - IRCCS San Raffaele Scientific Institute|UniversitÃ  Vita-Salute San Raffaele",Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milan|Milano,Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Lombardy|Mi,2012|20132|20132|20132|20132|20132|20132|20132|20132|20132|20132|2132|20132,Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy,13
"ClinicalTrials.gov processed this data on April 24, 2020",2020-04-02,NA,NA,2020-04-14,2020-04-03,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-14,2020-04-15,Actual,"April 7, 2020",Actual,2020-04-07,April 2020,2020-04-30,"October 21, 2021",Anticipated,2021-10-21,"September 1, 2020",Anticipated,2020-09-01,NA,Observational,NA,,Rutgers COVID-19 Cohort Study,"Cohort Study of SARS-CoV-2 Incidence, Transmission, and Disease Severity in Healthcare Workers",Recruiting,NA,NA,750,Anticipated,"Rutgers, The State University of New Jersey",,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      nasopharyngeal or throat swabs, saliva, and blood (for detecting SARS-CoV-2 positivity and
      immunity)
    ",NA,NA,NA,No,NA,2020-04-25T09:18:12Z,2020-04-25T09:18:12Z,5111137,NCT04336215,Coronavirus Infections,coronavirus infections,Other,Non-Interventional,This non-interventional study poses no additional risks to people with pre-existing conditions.,1,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,Clinical Research Center Rutgers-Robert Wood Johnson Medical School RWJUH East Tower -|Robert Wood Johnson University Hospital|Clinical Research Unit Rutgers New Jersey Medical School|Rutgers School of Dental Medicine|University Hospital|Environmental and Occupational Health Sciences Institute|RUCDR Infinite Biologics,New Brunswick|New Brunswick|Newark|Newark|Newark|Piscataway|Piscataway,New Jersey|New Jersey|New Jersey|New Jersey|New Jersey|New Jersey|New Jersey,08901|08901|07103|07103|07103|08854|08854,United States|United States|United States|United States|United States|United States|United States,7
"ClinicalTrials.gov processed this data on April 22, 2020",2020-04-08,NA,NA,2020-04-10,2020-04-08,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-13,Actual,"March 25, 2020",Actual,2020-03-25,April 2020,2020-04-30,March 2021,Anticipated,2021-03-31,March 2021,Anticipated,2021-03-31,NA,Observational,NA,,Acquiring Convalescent Specimens for COVID-19 Antibodies,Acquiring Convalescent Specimens to Isolate and Identify Potent Monoclonal Antibodies Against COVID-19,Recruiting,NA,NA,12,Anticipated,Columbia University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Whole blood from which peripheral blood mononuclear cells (PBMCs) and plasma will be
      processed.
    ",NA,NA,NA,NA,NA,2020-04-23T09:13:43Z,2020-04-23T09:13:43Z,5086781,NCT04342195,Coronavirus Infections,coronavirus infections,Procedure,Blood draw,Participants will have approximately 45 ml of whole blood drawn (3 Tablespoons) drawn at the study visit.,1,Recruiting,Columbia University Irving Medical Center/NYP,New York,New York,10032,United States,1
"ClinicalTrials.gov processed this data on April 17, 2020",2020-04-01,NA,NA,2020-04-06,2020-04-01,2020-04-03,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-08,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,September 2020,Anticipated,2020-09-30,September 2020,Anticipated,2020-09-30,NA,Observational,TOVID-49,,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Recruiting,NA,NA,100,Anticipated,"University Hospital, Angers",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-18T09:11:23Z,2020-04-18T09:11:23Z,5035816,NCT04333849,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Angers University Hospital,Angers,,49933,France,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-27,NA,NA,2020-04-27,2020-04-27,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"April 28, 2020",Anticipated,2020-04-28,April 2020,2020-04-30,April 2021,Anticipated,2021-04-30,April 2021,Anticipated,2021-04-30,NA,Observational,NA,,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",ScreenNC: A Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the SARS-CoV-2 Infection,Enrolling by invitation,NA,NA,10000,Anticipated,"University of North Carolina, Chapel Hill",,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Blood; virus from nasal or oral swab
    ",NA,NA,NA,No,NA,2020-04-30T09:06:56Z,2020-04-30T09:06:56Z,5165313,NCT04367740,Coronavirus Infections,coronavirus infections,Diagnostic Test,To assess for development of IgG antibodies against SARS-CoV2,Swabs will be collected to assess for COVID-19 if PPE supplies allow.,1,,"Center for Environmental Medicine, Asthma and Lung Biology",Chapel Hill,North Carolina,27599,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-17,NA,NA,2020-04-28,2020-04-28,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-29,Estimate,"March 8, 2020",Actual,2020-03-08,April 2020,2020-04-30,"May 31, 2020",Anticipated,2020-05-31,"May 31, 2020",Anticipated,2020-05-31,NA,Observational,NA,,Social Media and COVID-19,Getting it Right: Towards Responsible Social Media Use During a Pandemic (COVID-19),Recruiting,NA,NA,150,Anticipated,Yale-NUS College,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,"Due to stipulations by the Institutional Review Board, data cannot be shared.",2020-04-30T09:07:09Z,2020-04-30T09:07:09Z,5165359,NCT04367363,Coronavirus Infections,coronavirus infections,Behavioral,Social media & news consumption,"Daily reports of social media use and consumption, including reports on receiving and disseminating news articles related to the COVID-19 situation (e.g., how many messaging groups shared news on the outbreak, how many items related to the outbreak they forwarded to others, etc).",1,Recruiting,Yale-NUS College,Singapore,,138527,Singapore,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-16,NA,NA,2020-04-27,2020-04-27,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"April 14, 2020",Actual,2020-04-14,April 2020,2020-04-30,"December 1, 2021",Anticipated,2021-12-01,"December 1, 2020",Anticipated,2020-12-01,NA,Observational,ELCOVID,,Electrocardiogram Analysis in COVID-19 Patients,Electrocardiogram Analysis in COVID-19 Patients,Recruiting,NA,NA,1000,Anticipated,University Hospital of Ferrara,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,not yet decided a plan to share individual participant data (IPD),2020-04-30T09:07:17Z,2020-04-30T09:07:17Z,5165389,NCT04367129,Coronavirus Infections,coronavirus infections,Diagnostic Test,ECG,12 lead electrocardiogram,1,Recruiting,Arcispedale S. Anna,Ferrara,,44124,Italy,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-22,NA,NA,2020-04-27,2020-04-27,2020-04-29,Estimate,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"April 30, 2020",Anticipated,2020-04-30,April 2020,2020-04-30,"September 15, 2022",Anticipated,2022-09-15,"September 15, 2022",Anticipated,2022-09-15,NA,Observational,COVIDSMELL,,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Not yet recruiting,NA,NA,24,Anticipated,Institut Pasteur,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Nasal swabs
    ",NA,NA,NA,No,NA,2020-04-30T09:07:24Z,2020-04-30T09:07:24Z,5165408,NCT04366934,Coronavirus Infections,coronavirus infections,Other|Other,Nasal swab|Taste and olfactory function evaluation,Nasal swab|Taste and olfactory function evaluation,2,,HÃ´pital LariboisiÃ¨re,Paris,,,France,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-23,NA,NA,2020-04-26,2020-04-23,2020-04-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-26,2020-04-28,Actual,"April 20, 2020",Actual,2020-04-20,April 2020,2020-04-30,"October 1, 2031",Anticipated,2031-10-01,"April 20, 2030",Anticipated,2030-04-20,NA,Observational,ACCESS,,ACCESS A Master Digital Surveillance Protocol for COVID-19,"ACCESS (American COVID-19 Collaborative, Enabling Seamless Science) Master Digital Surveillance and Associated Clinical Trials Protocol for COVID-19",Recruiting,NA,NA,1000000,Anticipated,Medable Inc.,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,Please reach out to the study team for data sharing policies and procedures. Only de-identified and aggregate data may be considered for sharing.,2020-04-30T09:09:40Z,2020-04-30T09:09:40Z,5165852,NCT04363268,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Medable Inc.,Palo Alto,California,94301,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-22,NA,NA,2020-04-24,2020-04-24,2020-04-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-24,2020-04-27,Actual,"April 23, 2020",Actual,2020-04-23,April 2020,2020-04-30,"March 20, 2025",Anticipated,2025-03-20,"April 20, 2021",Anticipated,2021-04-20,NA,Observational,NA,,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,SJTRC-St. Jude Tracking of Viral and Host Factors Associated With COVID-19: A Prospective Adaptive Cohort Study,Recruiting,NA,NA,1517,Anticipated,St. Jude Children's Research Hospital,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      blood and nasal samples
    ",NA,NA,NA,NA,NA,2020-04-30T09:09:49Z,2020-04-30T09:09:49Z,5165884,NCT04362995,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,St. Jude Children's Research Hospital,Memphis,Tennessee,38105,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-23,NA,NA,2020-04-27,2020-04-23,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"April 21, 2020",Actual,2020-04-21,April 2020,2020-04-30,"December 21, 2024",Anticipated,2024-12-21,"December 31, 2022",Anticipated,2022-12-31,NA,Observational,LIINC,,Long-term Impact of Infection With Novel Coronavirus (COVID-19),Long-term Impact of Infection With Novel Coronavirus (LIINC): An Observational Study,Recruiting,NA,NA,800,Anticipated,"University of California, San Francisco",,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Whole blood, peripheral blood mononuclear cells, plasma, serum, and saliva.
    ",NA,NA,NA,No,NA,2020-04-30T09:10:20Z,2020-04-30T09:10:20Z,5165976,NCT04362150,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Zuckerberg San Francisco General Hospital (ZSFG),San Francisco,California,94110,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-14,NA,NA,2020-04-23,2020-04-23,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-23,2020-04-24,Actual,"April 25, 2020",Anticipated,2020-04-25,April 2020,2020-04-30,"May 31, 2020",Anticipated,2020-05-31,"May 24, 2020",Anticipated,2020-05-24,NA,Observational,RESPIRE,,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,COVID-19: Ruxolitinib for the Treatment of cytokinE Storm resPiratory dIstREss Syndrome. RESPIRE Study,Not yet recruiting,NA,NA,13,Anticipated,Azienda USL Toscana Nord Ovest,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:10:29Z,2020-04-30T09:10:29Z,5165997,NCT04361903,Coronavirus Infections,coronavirus infections,Drug,Ruxolitinib Oral Tablet,Ruxolitinib Oral Tablet dosage of at least 20 mg x 2 / day in the first 48 hours,1,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-22,NA,NA,2020-04-22,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,December 2021,Anticipated,2021-12-31,December 2021,Anticipated,2021-12-31,NA,Observational,NA,,Atrium COVID-19 Syndromic and Serologic Surveillance,"A Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records",Not yet recruiting,NA,NA,450000,Anticipated,Atrium Health,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:11:00Z,2020-04-30T09:11:00Z,5166093,NCT04361123,Coronavirus Infections,coronavirus infections,Other|Diagnostic Test,daily syndromic surveillance|monthly serologic IgM/G test,"Each volunteer will be securely linked to an Oracle developed, self-reporting online HIPAA-compliant data system through a secure app on their smartphone, tablet, or computer. Volunteers will report their illness symptoms daily, health seeking behavior and treatment, COVID-19 contacts, and, for health care workers, use of PPE.|At baseline to measure seroprevalence, and once every month after to detect seroconversions, we will use serological antibody tests for SARS-CoV-2 on a sample of volunteers demographically representative of populations served by Atrium Health.",2,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-20,NA,NA,2020-04-24,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-24,2020-04-28,Actual,"April 27, 2020",Anticipated,2020-04-27,April 2020,2020-04-30,"October 27, 2020",Anticipated,2020-10-27,"October 27, 2020",Anticipated,2020-10-27,NA,Observational,NA,,Evaluation of Antibody Tests for COVID-19,Evaluation of Commerical Antibody Tests for COVID-19,Recruiting,NA,NA,1000,Anticipated,Washington University School of Medicine,,NA,4,NA,FALSE,NA,NA,NA,FALSE,NA,NA,NA,NA,NA,Samples Without DNA,"
      Plasma or serum.
    ",NA,NA,NA,NA,NA,2020-04-30T09:11:06Z,2020-04-30T09:11:06Z,5166113,NCT04360954,Coronavirus Infections,coronavirus infections,Diagnostic Test,Diagnostic test,There is no intervention. This study will test deidentified archived biosamples.,1,Recruiting,Washington University School of Medicine,Saint Louis,Missouri,63110,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-16,NA,NA,2020-04-22,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 8, 2020",Actual,2020-04-08,April 2020,2020-04-30,"December 30, 2021",Anticipated,2021-12-30,"July 1, 2021",Anticipated,2021-07-01,NA,Observational,COVID19 LTFU,,Long Term Outcomes of Patients With COVID-19,Long Term Outcomes of Patients With COVID-19,Recruiting,NA,NA,500,Anticipated,University of Chicago,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:11:21Z,2020-04-30T09:11:21Z,5166149,NCT04360538,Coronavirus Infections,coronavirus infections,Other|Other|Other,Quality of Life|Impact Event Score|Hospital anxiety and depression scale,Physical disability assessment tool|Psychological Sequelae assessment tool|Psychological Sequelae assessment tool,3,Recruiting,University of Chicago Medical Center,Chicago,Illinois,60637,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-20,NA,NA,2020-04-20,2020-04-20,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-24,Actual,May 2020,Anticipated,2020-05-31,April 2020,2020-04-30,September 2022,Anticipated,2022-09-30,May 2022,Anticipated,2022-05-31,NA,Observational,STOP COVID 19,,Sequencing and Tracking of Phylogeny in COVID-19 Study,Sequencing and Tracking of Phylogeny in COVID-19 Study,Recruiting,NA,NA,500,Anticipated,Portsmouth Hospitals NHS Trust,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:11:44Z,2020-04-30T09:11:44Z,5166236,NCT04359849,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,"Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital",Portsmouth,Hampshire,PO6 3LY,United Kingdom,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-20,NA,NA,2020-04-20,2020-04-20,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-24,Actual,"April 16, 2020",Actual,2020-04-16,April 2020,2020-04-30,"July 31, 2021",Anticipated,2021-07-31,"April 30, 2021",Anticipated,2021-04-30,NA,Observational,NA,,A Study to Explore the Role of Gut Flora in COVID-19 Infection,A Non-Interventional Pilot Study to Explore the Role of Gut Flora in COVID-19 Infection,Recruiting,NA,NA,250,Anticipated,ProgenaBiome,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Stool samples.
    ",NA,NA,NA,No,NA,2020-04-30T09:11:45Z,2020-04-30T09:11:45Z,5166240,NCT04359836,Coronavirus Infections,coronavirus infections,Other,There is no intervention in this study,There is no intervention in this study,1,Recruiting,ProgenaBiome,Ventura,California,93003,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-20,NA,NA,2020-04-22,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 27, 2020",Anticipated,2020-04-27,April 2020,2020-04-30,"January 31, 2021",Anticipated,2021-01-31,"December 31, 2020",Anticipated,2020-12-31,NA,Observational,COVID_EIT,,Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID Patients,The Effect of Prone Positioning on Lung Aeration and Ventilation-perfusion Matching in Mechanically Ventilated Patients With Coronavirus Disease Related Acute Respiratory Distress Syndrome,Not yet recruiting,NA,NA,16,Anticipated,"University Hospital, Geneva",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:12:01Z,2020-04-30T09:12:01Z,5166285,NCT04359407,Coronavirus Infections,coronavirus infections,Other,Prone positioning,Change the positioning of the COVID patients who are intubated and mechanically ventilated from supine to prone,1,,University Hospitals of Geneva,Geneva,,1206,Switzerland,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-21,NA,NA,2020-04-21,2020-04-21,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-24,Actual,"April 9, 2020",Actual,2020-04-09,April 2020,2020-04-30,"April 22, 2020",Anticipated,2020-04-22,"April 22, 2020",Anticipated,2020-04-22,NA,Observational,PSY_CO_CHU,,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Recruiting,NA,NA,2000,Anticipated,Centre Hospitalier Universitaire de NÄ«mes,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:12:27Z,2020-04-30T09:12:27Z,5166366,NCT04358640,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Intensive care unit CHU Nimes,NÃ®mes,,30029,France,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-20,NA,NA,2020-04-20,2020-04-20,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-22,Actual,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,December 2020,Anticipated,2020-12-31,August 2020,Anticipated,2020-08-31,NA,Observational,NA,,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device,Not yet recruiting,NA,NA,300,Anticipated,"Kaligia Biosciences, LLC",,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-30T09:12:50Z,2020-04-30T09:12:50Z,5166446,NCT04357977,Coronavirus Infections,coronavirus infections,Diagnostic Test,RBA-2,Collection of non-invasive in vivo saliva from confirmed cases of both infected and non-infected COVID-19 patients or site staff at the testing site and compare the test results using the RBA-2 against the standard test results used for diagnosis.,1,||,Tampa General Hospital|University of South Florida|AdventHealth Tampa,Tampa|Tampa|Tampa,Florida|Florida|Florida,33606|33612|33613,United States|United States|United States,3
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-20,NA,NA,2020-04-21,2020-04-21,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-22,Actual,"April 15, 2020",Actual,2020-04-15,April 2020,2020-04-30,"April 30, 2020",Anticipated,2020-04-30,"April 20, 2020",Anticipated,2020-04-20,NA,Observational,SCout,,Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections,Risk Stratification With Chest Computed Tomography to Rule-out Suspected SARS-CoV-2 Infections of Unspecific Symptomatic Patients Before Hospital Admission,"Active, not recruiting",NA,NA,145,Anticipated,Jena University Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,There is not a plan to make IPD available.,2020-04-30T09:12:51Z,2020-04-30T09:12:51Z,5166451,NCT04357938,Coronavirus Infections,coronavirus infections,Device,CT-imaging,"Chest CT to rule out pneumonia in PCR negative, nonspecific symptomatic patients to prevent the spread of SARS-CoV-2 within the hospital.",1,,Jena University Hospital,Jena,Thuringia,07747,Germany,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-20,NA,NA,2020-04-22,2020-04-20,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,May 2020,Anticipated,2020-05-31,April 2020,2020-04-30,June 2020,Anticipated,2020-06-30,May 2020,Anticipated,2020-05-31,NA,Observational,NA,,Comparison of New Coronavirus (COVID-19) Awareness in Individuals of Different Age Groups: Analysis of Turkey,New Coronavirus Awareness,Not yet recruiting,NA,NA,1000,Anticipated,Istanbul University-Cerrahpasa,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:12:53Z,2020-04-30T09:12:53Z,5166457,NCT04357886,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,,Istanbul University-Cerrahpasa,Istanbul,,,Turkey,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-19,NA,NA,2020-04-21,2020-04-21,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-22,Actual,"April 12, 2020",Actual,2020-04-12,April 2020,2020-04-30,"September 30, 2020",Anticipated,2020-09-30,"July 31, 2020",Anticipated,2020-07-31,NA,Observational,NA,,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,Prognosis of Patients With Coronavirus Disease 2019 (COVID-19) Receiving Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Antagonists (ARBs),Recruiting,NA,NA,226,Anticipated,King Faisal Specialist Hospital & Research Center,,NA,1,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,Undecided,"On publication, according to the journal requirements",2020-04-30T09:13:05Z,2020-04-30T09:13:05Z,5166499,NCT04357535,Coronavirus Infections,coronavirus infections,Drug,Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB),ACE-I and ARB are a class of blood pressure lowering medications used to manage hypertension.,1,Recruiting,King Faisal Specialist Hospital & Research Centre,Riyadh,,11211,Saudi Arabia,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-17,NA,NA,2020-04-21,2020-04-21,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-22,Actual,"May 1, 2020",Anticipated,2020-05-01,April 2020,2020-04-30,"February 1, 2022",Anticipated,2022-02-01,"September 1, 2021",Anticipated,2021-09-01,NA,Observational,CAPACoV19,,Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation,Long Term Physical Functional Performance in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation: a Multicentric Observational Study,Not yet recruiting,NA,NA,300,Anticipated,CHU de Reims,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:13:44Z,2020-04-30T09:13:44Z,5166646,NCT04356378,Coronavirus Infections,coronavirus infections,Other,Data record,Data record,1,,Damien JOLLY,Reims,,,France,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-17,NA,NA,2020-04-28,2020-04-17,2020-04-21,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-29,Estimate,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,October 2020,Anticipated,2020-10-31,July 2020,Anticipated,2020-07-31,NA,Observational,NA,,Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.,AntikÃ¶rperseroprÃ¤valenz Und Hintergrundinfektionsrate Von SARS-CoV-2 in Einem Ã¶sterreichischen SchlÃ¼sselkollektiv an Arbeitnehmer*Innen,Not yet recruiting,NA,NA,4000,Anticipated,AUVA,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,IPD will be encrypted and anonymised.,2020-04-30T09:14:42Z,2020-04-30T09:14:42Z,5166836,NCT04354779,Coronavirus Infections,coronavirus infections,Diagnostic Test,a specifically designed self-administered questionnaire,"The questionnaire consists of the following items: questions related to personal health, traveling activities, living situation, as well as inquiries of symptoms and comorbidities.",1,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-12,NA,NA,2020-04-16,2020-04-16,2020-04-21,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-21,Actual,"March 31, 2020",Actual,2020-03-31,April 2020,2020-04-30,"May 31, 2020",Anticipated,2020-05-31,"May 1, 2020",Anticipated,2020-05-01,NA,Observational,TARUS,,The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic,The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic: TARUS,Recruiting,NA,NA,3000,Anticipated,Ariel University,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-30T09:15:14Z,2020-04-30T09:15:14Z,5166931,NCT04353934,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Ariel University,Ariel,,4070000,Israel,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-15,NA,NA,2020-04-15,2020-04-15,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-15,2020-04-20,Actual,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,December 2020,Anticipated,2020-12-31,November 2020,Anticipated,2020-11-30,NA,Observational,CALYPSO,,WGS ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS,WHOLE GENOME SEQUENCING ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS,Enrolling by invitation,NA,NA,5000,Anticipated,Vanda Pharmaceuticals,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-04-30T09:15:33Z,2020-04-30T09:15:33Z,5166990,NCT04353401,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,,"Vanda Pharmaceuticals, Inc.",Washington,District of Columbia,20037,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-16,NA,NA,2020-04-18,2020-04-17,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-18,2020-04-21,Actual,"February 19, 2020",Actual,2020-02-19,April 2020,2020-04-30,"April 6, 2020",Actual,2020-04-06,"April 4, 2020",Actual,2020-04-04,NA,Observational,NA,,Echocardiographic Manifestation in Patient With Coronavirus Disease 2019 (COVID-19),Cardiac Structural and Functional Characteristics in Coronavirus Disease 2019 (COVID-19): A Dynamic Echocardiographic Study,Completed,NA,NA,55,Actual,RenJi Hospital,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:15:52Z,2020-04-30T09:15:52Z,5167069,NCT04352842,Coronavirus Infections,coronavirus infections,Other,Echocardiography,"An expert with 17-year professional experience performed all the echocardiography examinations using a GE LOGIQTM e portable color ultrasound diagnostic machine (GE Healthcare, WI, USA) that was specially used in the contaminated area. Two-dimensional and Doppler echocardiographic measurements were conducted following the recommendations of the American Society of Echocardiography",1,,"Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University",Shanghai,Shanghai,200127,China,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-16,NA,NA,2020-04-20,2020-04-16,2020-04-17,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-22,Actual,"April 20, 2020",Anticipated,2020-04-20,April 2020,2020-04-30,"August 31, 2026",Anticipated,2026-08-31,"December 31, 2025",Anticipated,2025-12-31,NA,Observational,ReCovER,,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,Not yet recruiting,NA,NA,500,Anticipated,University of Cologne,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:16:21Z,2020-04-30T09:16:21Z,5167152,NCT04351854,Coronavirus Infections,coronavirus infections,Other,Retrospective data collection,Retrospective data collection to identify predicting factors in the clinical picture of COVID-19 patients presenting to the ED.,1,,University Hospital of Cologne,Cologne,,50937,Germany,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-15,NA,NA,2020-04-22,2020-04-15,2020-04-17,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 9, 2020",Actual,2020-04-09,April 2020,2020-04-30,April 2022,Anticipated,2022-04-30,April 2022,Anticipated,2022-04-30,NA,Observational,NA,,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City,Recruiting,NA,NA,10000,Anticipated,"University Hospital, Basel, Switzerland",,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-30T09:16:25Z,2020-04-30T09:16:25Z,5167165,NCT04351503,Coronavirus Infections,coronavirus infections,Other|Other|Other,Study A|Study B|Study C,"Study A: collection of data of clinical outcomes and features of SARS-CoV-2 infection. Demographical, clinical, microbiological, laboratory, epidemiological and hospital-associated data will be analyzed. For this study part, only patients with a visit at the University Hospital Basel will be included in order to access patient charts.|Study B: collection of epidemiological surveillance data to describe the epidemiology of the SARS-CoV-2 outbreak. The epidemic transmission of Influenza viruses in the City of Basel serves as an important reference to identify similarities and differences to the pandemic SARS-CoV-2 situation. In addition data collected during the Influenza projects - in particular data on statistical blocks of the city, e.g. population density, income and living space will be re-used. Already collected and stored samples such as serum and respiratory material (leftover material) will be (re-) used.|Study C: data collection for viral evolution. Respiratory materials and matching blood and tissue materials will be used to perform whole genome sequencing to study pathogen evolution between hosts as well as in-host evolution. No additional material will be collected.",3,Recruiting|Recruiting|Recruiting|Recruiting|Recruiting|Recruiting,Viollier AG|University Hospital Basel|Biozentrum University of Basel|sciCore University of Basel|Department of Biosystems Science and Engineering ETH Zurich|Swiss Institute of Bioinformatics,Allschwil|Basel|Basel|Basel|Basel|Geneva,|||||,4123|4031|4056|4056|4058|1202,Switzerland|Switzerland|Switzerland|Switzerland|Switzerland|Switzerland,6
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-13,NA,NA,2020-04-26,2020-04-13,2020-04-16,Actual,NA,NA,NA,NA,NA,NA,2020-04-26,2020-04-28,Actual,"April 10, 2020",Actual,2020-04-10,April 2020,2020-04-30,June 2021,Anticipated,2021-06-30,June 2021,Anticipated,2021-06-30,NA,Observational,BLAST COVID-19,,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Recruiting,NA,NA,50000,Anticipated,William Beaumont Hospitals,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,TRUE,NA,NA,FALSE,Samples With DNA,"
      Whole blood and serum
    ",NA,NA,NA,No,NA,2020-04-30T09:16:46Z,2020-04-30T09:16:46Z,5167240,NCT04349202,Coronavirus Infections,coronavirus infections,Diagnostic Test,EUROIMMUN assay,Serology testing to detect SARS-CoV-2 antibodies,1,Recruiting|Not yet recruiting,Beaumont Health System|Beaumont Health,Royal Oak|Royal Oak,Michigan|Michigan,48073|48073,United States|United States,2
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-13,NA,NA,2020-04-17,2020-04-14,2020-04-16,Actual,NA,NA,NA,NA,NA,NA,2020-04-17,2020-04-20,Actual,"April 20, 2020",Anticipated,2020-04-20,April 2020,2020-04-30,"December 1, 2020",Anticipated,2020-12-01,"October 1, 2020",Anticipated,2020-10-01,NA,Observational,NA,,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,Screening and Risk Assessment of Healthcare Workers and Infection Control in University and COVID-19 Quarantine Hospitals Using Real-time Geospatial Mapping for Emergency Healthcare Resource Mobilization and Management,Not yet recruiting,NA,NA,3000,Anticipated,Ain Shams University,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:16:57Z,2020-04-30T09:16:57Z,5167279,NCT04348214,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,,Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center,Cairo,Non-US,11566,Egypt,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-13,NA,NA,2020-04-17,2020-04-14,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-04-17,2020-04-20,Actual,"April 14, 2020",Actual,2020-04-14,April 2020,2020-04-30,"December 1, 2020",Anticipated,2020-12-01,"October 1, 2020",Anticipated,2020-10-01,NA,Observational,Explore,,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Retrospective Study From November 2019 -Febrauary 2020 on Severe Respiratory Illness to Access the Presence or Absence of COVID-19 in Patients Samples by Real-time PcR,Recruiting,NA,NA,500,Anticipated,Ain Shams University,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Oropharyngeal and nasopharyngeal swabs for hospitalized SARI patients who meet the WHO
      standard SARI case definition.
    ",NA,NA,NA,No,NA,2020-04-30T09:17:10Z,2020-04-30T09:17:10Z,5167304,NCT04346056,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting|Recruiting,Faculty of Medicine Ain Shams University|Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center,Cairo|Cairo,Non-US|Non-US,11556|11566,Egypt|Egypt,2
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-13,NA,NA,2020-04-17,2020-04-13,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-04-17,2020-04-20,Actual,"April 20, 2020",Anticipated,2020-04-20,April 2020,2020-04-30,"December 1, 2020",Anticipated,2020-12-01,"October 1, 2020",Anticipated,2020-10-01,NA,Observational,Strain,,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,Strain Study: To Access the Egyptian COVID-19 Whole Genome (Dominant Strain) by Next Generation Sequencing (NGS) and Compare to the International Worldwide Database,Not yet recruiting,NA,NA,100,Anticipated,Ain Shams University,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Nasopharyngeal & oropharyngeal swabs will be taken from patients with COVID-19
    ",NA,NA,NA,No,NA,2020-04-30T09:17:11Z,2020-04-30T09:17:11Z,5167305,NCT04346043,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,,Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center,Cairo,Non-US,11556,Egypt,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-13,NA,NA,2020-04-27,2020-04-13,2020-04-14,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"May 15, 2020",Anticipated,2020-05-15,April 2020,2020-04-30,"April 1, 2025",Anticipated,2025-04-01,"July 1, 2024",Anticipated,2024-07-01,NA,Observational,NIAID,,Collection of Anti-SARS-CoV-2 Immune Plasma,A Pilot Study for Collection of Anti-SARS-CoV-2 Immune Plasma,Recruiting,NA,NA,1500,Anticipated,National Institutes of Health Clinical Center (CC),,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Serum, plasma
    ",NA,NA,NA,NA,NA,2020-04-30T09:17:17Z,2020-04-30T09:17:17Z,5167326,NCT04344977,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Bloodworks Northwest,Seattle,Washington,98104,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-04-08,NA,NA,2020-04-27,2020-04-08,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"April 8, 2020",Actual,2020-04-08,April 2020,2020-04-30,December 2021,Anticipated,2021-12-31,December 2021,Anticipated,2021-12-31,NA,Observational,NA,,COVID-19 Community Research Partnership,"A Multicenter, Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records","Active, not recruiting",NA,NA,150000,Anticipated,Wake Forest University Health Sciences,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-30T09:17:28Z,2020-04-30T09:17:28Z,5167358,NCT04342884,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,,Wake Forest Baptist Medical Center,Winston-Salem,North Carolina,27157,United States,1
"ClinicalTrials.gov processed this data on April 29, 2020",2020-03-26,NA,NA,2020-04-27,2020-03-26,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Estimate,"March 13, 2020",Actual,2020-03-13,April 2020,2020-04-30,"February 28, 2023",Anticipated,2023-02-28,"February 28, 2021",Anticipated,2021-02-28,NA,Observational,CORSER,,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples,Recruiting,NA,NA,1000,Anticipated,Institut Pasteur,,NA,6,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      serum, plasma
    ",NA,NA,NA,Undecided,NA,2020-04-30T09:18:30Z,2020-04-30T09:18:30Z,5167586,NCT04325646,Coronavirus Infections,coronavirus infections,Other,Human Biological samples,Blood samples for serological tests,1,Completed|Completed|Recruiting|Recruiting|Completed|Recruiting|Completed|Completed|Recruiting|Recruiting|Completed|Completed|Completed|Completed|Completed|Completed,CHU Amiens-Picardie|CHU FranÃ§ois Mitterand|Centre Hospitalier DÃ©partemental de VendÃ©e|CHU Limoges|HÃ´pital de la Croix Rousse|CHRU de Nancy|HÃ´pitaux de Brabois|CHR OrlÃ©ans|Institut Pasteur|HÃ´pital la PitiÃ© SalpetriÃ¨re|CHU Poitiers|HÃ´pital Pontchaillou|CHU Saint-Etienne|CHRU de Strasbourg|CH de Tourcoing|HÃ´pital Bretonneau,Amiens|Dijon|La Roche-sur-Yon|Limoges|Lyon|Nancy|Nancy|OrlÃ©ans|Paris|Paris|Poitiers|Rennes|Saint-Ã‰tienne|Strasbourg|Tourcoing|Tours,|||||||||||||||,||||||||75015|||||||,France|France|France|France|France|France|France|France|France|France|France|France|France|France|France|France,16
"ClinicalTrials.gov processed this data on April 17, 2020",2020-03-31,NA,NA,2020-04-04,2020-04-04,2020-04-08,Actual,NA,NA,NA,NA,NA,NA,2020-04-04,2020-04-08,Actual,"April 6, 2020",Anticipated,2020-04-06,March 2020,2020-03-31,"January 29, 2021",Anticipated,2021-01-29,"December 29, 2020",Anticipated,2020-12-29,NA,Observational,POCUSCO,,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Point Of Care UltraSonography to Perform Risk-stratification of Patients With Suspected or Confirmed COVID-19 - POCUSCO Study,Not yet recruiting,NA,NA,300,Anticipated,"University Hospital, Angers",,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-18T09:10:37Z,2020-04-18T09:10:37Z,5035657,NCT04338100,Coronavirus Infections,coronavirus infections,Procedure,Follow-up at 14 days,Point of care chest ultrasonography and 14-day follow-up to assess the evolution of the infection and care requirement (invasive ventilation or death),1,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 08, 2020",2020-03-26,NA,NA,2020-03-26,2020-03-26,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-30,Actual,"March 25, 2020",Actual,2020-03-25,March 2020,2020-03-31,"September 25, 2022",Anticipated,2022-09-25,"September 25, 2022",Anticipated,2022-09-25,NA,Observational,NA,,Audio Data Collection for Identification and Classification of Coughing,Audio Data Collection for Identification and Classification of Coughing,Recruiting,NA,NA,1000,Anticipated,HealthMode Inc.,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-09T09:14:27Z,2020-04-09T09:14:27Z,4926554,NCT04326309,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Virtual Facility,Bronx,New York,10461,United States,1
"ClinicalTrials.gov processed this data on April 03, 2020",2020-03-24,NA,NA,2020-03-26,2020-03-26,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-27,Actual,"April 1, 2020",Anticipated,2020-04-01,March 2020,2020-03-31,December 2020,Anticipated,2020-12-31,November 2020,Anticipated,2020-11-30,NA,Observational,NA,,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Not yet recruiting,NA,NA,300,Anticipated,Universita di Verona,,NA,3,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Nasopharyngeal swabs
    ",NA,NA,NA,NA,NA,2020-04-06T08:55:08Z,2020-04-06T08:55:08Z,4894228,NCT04324866,Coronavirus Infections,coronavirus infections,Diagnostic Test,Nasopharyngeal swab,Nasopharyngeal swab for the molecular diagnosis of COVID-19 infection,1,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 22, 2020",2020-04-03,NA,NA,2020-04-09,2020-04-03,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-13,Actual,"April 12, 2020",Anticipated,2020-04-12,April 2020,2020-04-30,"June 10, 2020",Anticipated,2020-06-10,"May 10, 2020",Anticipated,2020-05-10,NA,Observational,NA,,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine","Determination Of Physical Activity, Sleep And Stress Level Of Pregnant Women In The CovÄ±d-19 Quarantine Period",Not yet recruiting,NA,NA,100,Anticipated,Istanbul KÃ¼ltÃ¼r University,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-23T09:14:28Z,2020-04-23T09:14:28Z,5086912,NCT04336787,Coronavirus Infections,coronavirus infections,Other,Survey,"A Google Survey which included that consent form, demographic information form, International Physical Activity Questionnaire, Pittsburgh Sleep Quality Index, Perceived Stress Scale and The Numeric Rating Scale will be created. Then the survey link will be shared via social media such as Whatsapp, Facebook, etc.",1,,Istanbul University - CerrahpaÅŸa,Istanbul,,,Turkey,1
"ClinicalTrials.gov processed this data on April 03, 2020",2020-03-25,NA,NA,2020-03-25,2020-03-25,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-26,Actual,"March 31, 2020",Anticipated,2020-03-31,March 2020,2020-03-31,"September 30, 2020",Anticipated,2020-09-30,"September 30, 2020",Anticipated,2020-09-30,NA,Observational,CovidSurg,,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Not yet recruiting,NA,NA,1000,Anticipated,University of Birmingham,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,No individual participant data will be available to other researchers,2020-04-05T09:04:25Z,2020-04-05T09:04:25Z,4883038,NCT04323644,Coronavirus Infections,coronavirus infections,Procedure,Surgery,Emergency or elective surgery,1,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 03, 2020",2020-03-24,NA,NA,2020-03-24,2020-03-24,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-24,2020-03-26,Actual,"March 9, 2020",Actual,2020-03-09,March 2020,2020-03-31,"May 1, 2020",Anticipated,2020-05-01,"May 1, 2020",Anticipated,2020-05-01,NA,Observational,NA,,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection (CoV-CONTACT-SERO),Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection,Recruiting,NA,NA,300,Anticipated,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France",,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood samples
    ",NA,NA,NA,Undecided,NA,2020-04-05T09:05:16Z,2020-04-05T09:05:16Z,4883242,NCT04322279,Coronavirus Infections,coronavirus infections,Diagnostic Test|Genetic,Serology|Sequencing,SARS-CoV-2 serology|Whole exome sequencing,2,Recruiting,CIC 1425,Paris,,,France,1
"ClinicalTrials.gov processed this data on April 08, 2020",2020-03-24,NA,NA,2020-03-26,2020-03-26,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-30,Actual,"February 24, 2020",Actual,2020-02-24,March 2020,2020-03-31,"June 17, 2021",Anticipated,2021-06-17,"February 28, 2021",Anticipated,2021-02-28,NA,Observational,NA,,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,"Comprehensive Clinical, Virological, Microbiological, Immunological and Laboratory Monitoring of Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)",Recruiting,NA,NA,170,Anticipated,Chinese University of Hong Kong,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-09T09:14:43Z,2020-04-09T09:14:43Z,4926615,NCT04325919,Coronavirus Infections,coronavirus infections,Other,No intervention,No intervention,1,Recruiting,Prince of Wales Hospital,Sha Tin,,,Hong Kong,1
"ClinicalTrials.gov processed this data on April 17, 2020",2020-04-06,NA,NA,2020-04-06,2020-04-06,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-09,Actual,"April 15, 2020",Anticipated,2020-04-15,April 2020,2020-04-30,October 2020,Anticipated,2020-10-31,October 2020,Anticipated,2020-10-31,NA,Observational,NA,,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Not yet recruiting,NA,NA,500,Anticipated,University of Minnesota,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-19T09:01:58Z,2020-04-19T09:01:58Z,5047273,NCT04339998,Coronavirus Infections,coronavirus infections,Diagnostic Test,Point-of-Care Ultrasonography (POCUS),"The POCUS exam of the heart will capture 2 standard views commonly used to assess general cardiac function at the point of care. The details of POCUS views and exam findings of interest are outline below:
Pulmonary POCUS Evaluation:
B lines: absent (< 3 lines), present (> 3 lines), fused
Consolidation: yes or no
a. Bilateral: yes or no
Pleural Effusion: yes or no
Other pleural abnormalities: yes or no Score each finding based on degree of abnormalities and number of sites with abnormalities
Cardiac POCUS Evaluation:
Parasternal long axis
Parasternal short axis
Qualitative LVEF: Normal, hyperdynamic, mild-moderately depressed, severely depressed
EPSS (E-point septal separation): normal (<10 mm), abnormal (>10 mm)
Left ventricular (LV) mass approximation by septal thickness
Left Ventricular Chamber Size by internal diameter at diastole",1,|,University of Minnesota Medical Center (UMMC)|M Health Fairview Bethesda Hospital,Minneapolis|Saint Paul,Minnesota|Minnesota,55455|55103,United States|United States,2
"ClinicalTrials.gov processed this data on April 17, 2020",2020-04-06,NA,NA,2020-04-06,2020-04-06,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-09,Actual,"March 1, 2020",Actual,2020-03-01,April 2020,2020-04-30,"April 15, 2020",Anticipated,2020-04-15,"April 15, 2020",Anticipated,2020-04-15,NA,Observational,NA,,COVID-19 Risk Stratification,COVID-19 Risk Stratification,Recruiting,NA,NA,1500,Anticipated,Brigham and Women's Hospital,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,Investigators may provide reasonable requests for IPD. These requests will be reviewed by the study team and institution on a case by case basis.,2020-04-19T09:02:22Z,2020-04-19T09:02:22Z,5047344,NCT04339387,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting,Brigham and Women's Hospital,Boston,Massachusetts,02115,United States,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-14,NA,NA,2020-03-14,2020-03-14,2020-03-17,Actual,NA,NA,NA,NA,NA,NA,2020-03-14,2020-03-17,Actual,"March 14, 2020",Anticipated,2020-03-14,March 2020,2020-03-31,"December 1, 2020",Anticipated,2020-12-01,"June 1, 2020",Anticipated,2020-06-01,NA,Observational,NA,,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Not yet recruiting,NA,NA,100,Anticipated,Huashan Hospital,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-01T09:19:39Z,2020-04-01T09:19:39Z,4274500,NCT04311398,Coronavirus Infections,coronavirus infections,Diagnostic Test,New QIAstat-Dx fully automatic multiple PCR detection platform,We use the New QIAstat-Dx fully automatic multiple PCR detection platform to test the enrolled patients,1,,Huashan Hospital of Fudan University,Shanghai,Shanghai,200040,China,1
"ClinicalTrials.gov processed this data on April 09, 2020",2020-03-23,NA,NA,2020-03-30,2020-03-23,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,April 2020,Anticipated,2020-04-30,March 2020,2020-03-31,March 2022,Anticipated,2022-03-31,March 2021,Anticipated,2021-03-31,NA,Observational,NA,,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,"COVID CT, Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2",Not yet recruiting,NA,NA,25,Anticipated,William Beaumont Hospitals,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,TRUE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-04-10T09:16:55Z,2020-04-10T09:16:55Z,4940269,NCT04320511,Coronavirus Infections,coronavirus infections,Device,CT-V,"CT-V is an image processing-based modality that recovers changes in local tissue volumes, induced by respiratory motion, from an inspiration-expiration CT (IE-CT) scan or a standard non-contrast 4D CT scan",1,,Beaumont Health,Royal Oak,Michigan,48073,United States,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-13,NA,NA,2020-03-14,2020-03-14,2020-03-18,Actual,NA,NA,NA,NA,NA,NA,2020-03-14,2020-03-18,Actual,"February 1, 2020",Actual,2020-02-01,March 2020,2020-03-31,February 2021,Anticipated,2021-02-28,October 2020,Anticipated,2020-10-31,NA,Observational,SOTSPC,,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Recruiting,NA,NA,30,Anticipated,Henan Provincial People's Hospital,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-04-01T09:19:34Z,2020-04-01T09:19:34Z,4274415,NCT04312100,Coronavirus Infections,coronavirus infections,Other,oxygen treatment,different kinds of oxygen treatments will be given to patients according to their state of illness,1,Recruiting,Henan Provincial People's Hospital,Zhengzhou,Henan,450000,China,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-05,NA,NA,2020-02-13,2020-02-05,2020-02-07,Actual,NA,NA,NA,NA,NA,NA,2020-02-13,2020-02-17,Actual,"February 4, 2020",Actual,2020-02-04,February 2020,2020-02-29,"February 4, 2021",Anticipated,2021-02-04,"October 4, 2020",Anticipated,2020-10-04,NA,Observational,Cov-CONTACT,,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,Recruiting,NA,NA,300,Anticipated,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Nasopharyngeal swabs
    ",NA,NA,NA,Undecided,NA,2020-04-01T09:26:21Z,2020-04-01T09:26:21Z,4280975,NCT04259892,Coronavirus Infections,coronavirus infections,Biological,2019-nCoV PCR,Nasopharyngeal swabs,1,Recruiting,CIC 1425,Paris,,75018,France,1
"ClinicalTrials.gov processed this data on April 17, 2020",2020-02-16,NA,NA,2020-04-07,2020-02-16,2020-02-18,Actual,NA,NA,NA,NA,NA,NA,2020-04-07,2020-04-08,Actual,"February 19, 2020",Actual,2020-02-19,April 2020,2020-04-30,July 2020,Anticipated,2020-07-31,"April 4, 2020",Actual,2020-04-04,NA,Observational,NA,,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool (COV_NUTRIC),"Active, not recruiting",NA,NA,117,Actual,Peking University Third Hospital,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-18T09:14:07Z,2020-04-18T09:14:07Z,5036434,NCT04274322,Coronavirus Infections,coronavirus infections,Other,Nutrition support,"Calories and proteins are given to patients by using ways as parenteral nutriton, enteral nutrition, oral nutrition supplement",1,,Peking University Third Hospital,Beijing,,,China,1
"ClinicalTrials.gov processed this data on April 24, 2020",2020-04-16,NA,NA,2020-04-16,2020-04-16,2020-04-17,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-17,Actual,"April 20, 2020",Anticipated,2020-04-20,April 2020,2020-04-30,"January 20, 2021",Anticipated,2021-01-20,"January 20, 2021",Anticipated,2021-01-20,NA,Observational,COR-DLUS,,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,Not yet recruiting,NA,NA,180,Anticipated,University Hospital Plymouth NHS Trust,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-27T08:58:23Z,2020-04-27T08:58:23Z,5134239,NCT04351802,Coronavirus Infections,coronavirus infections,Diagnostic Test,Lung ultrasound,Focused lung ultrasound examination,1,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 24, 2020",2020-03-31,NA,NA,2020-04-16,2020-04-01,2020-04-02,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-17,Actual,April 2020,Anticipated,2020-04-30,March 2020,2020-03-31,March 2021,Anticipated,2021-03-31,March 2021,Anticipated,2021-03-31,NA,Observational,COVID-19,,An Observational Study of Patients With Coronavirus Disease 2019,An Observational Study of Patients With Coronavirus Disease 2019,Not yet recruiting,NA,NA,5000,Anticipated,"Target PharmaSolutions, Inc.",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-27T09:01:08Z,2020-04-27T09:01:08Z,5134718,NCT04331886,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,,University of Washington,Seattle,Washington,98195,United States,1
"ClinicalTrials.gov processed this data on April 24, 2020",2020-02-18,NA,NA,2020-04-15,2020-02-18,2020-02-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-15,2020-04-17,Actual,"March 5, 2020",Actual,2020-03-05,October 2019,2019-10-31,"April 24, 2024",Anticipated,2024-04-24,"April 24, 2024",Anticipated,2024-04-24,NA,Observational,POPS or POP02,,"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs",Recruiting,NA,NA,5000,Anticipated,Duke University,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Whole blood, effluent samples, and plasma.
    ",NA,NA,NA,No,NA,2020-04-27T09:02:43Z,2020-04-27T09:02:43Z,5135048,NCT04278404,Coronavirus Infections,coronavirus infections,Drug,"The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:",The prescribing of drugs to children is not part of this protocol. Participants will receive DOIs as prescribed by their treating provider.,1,Not yet recruiting|Not yet recruiting|Recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting|Not yet recruiting,Arkansas Children's Hospital Research Institute|Colorado University Denver|Alfred I. DuPont Hospital for Children|University of Florida Jacksonville Shands Medical Center|Kapiolani Womens and Childrens Medical Center|Ann and Robert H. Lurie Childrens Hospital of Chicago|Riley Hospital for Children at Indiana University|University of Kansas Medical Center|Wesley Medical Center|University of Louisville Norton Childrens Hospital|Tulane University Health Science Center|Ochsner Baptist Clinical Trials Unit|University of Mississippi Medical Center|Childrens Mercy Hospital|University of Nebraska Medical Center|Dartmouth-Hitchcock Medical Center|University of New Mexico Health Science Center|Kravis Children's Hospital at Mt. Sinai|University of North Carolina at Chapel Hill|Duke University Health System|Cincinnati Childrens Hospital Medical Center|Board of Regents of the University of Oklahoma|Oregon Health and Science University|Rhode Island Hospital|Medical University of South Carolina Children's Hospital|University of South Carolina|University of South Carolina|Monroe Carell Jr. Children's Hospital at Vanderbilt|Dell Children's Medical Center of Central Texas|Seattle Children's Hospital|University Wisconsin|Medical College of Wisconsin,Little Rock|Aurora|Wilmington|Jacksonville|Honolulu|Chicago|Indianapolis|Kansas City|Wichita|Louisville|New Orleans|New Orleans|Jackson|Kansas City|Omaha|Lebanon|Albuquerque|New York|Chapel Hill|Durham|Cincinnati|Oklahoma City|Portland|Providence|Charleston|Columbia|Columbia|Nashville|Austin|Seattle|Madison|Milwaukee,Arkansas|Colorado|Delaware|Florida|Hawaii|Illinois|Indiana|Kansas|Kansas|Kentucky|Louisiana|Louisiana|Mississippi|Missouri|Nebraska|New Hampshire|New Mexico|New York|North Carolina|North Carolina|Ohio|Oklahoma|Oregon|Rhode Island|South Carolina|South Carolina|South Carolina|Tennessee|Texas|Washington|Wisconsin|Wisconsin,72202|80045|19803|32209|96826|60614|46202|66160|67214|40202|70112|70115|39216|64111|68114|03756|87131|10029|27599|27710|45229|73104|97239|02903|29425|29203|29203|37232|78723|98105|53705|53226,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States,32
"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-13,NA,NA,2020-03-15,2020-02-20,2020-02-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-15,2020-03-17,Actual,"February 21, 2020",Actual,2020-02-21,March 2020,2020-03-31,"July 30, 2020",Anticipated,2020-07-30,"May 30, 2020",Anticipated,2020-05-30,NA,Observational,NA,,Study for Novel Coronavirus Pneumonia (NCP),Study for Clinical Epidemiology and Methods of Diagnosis and Treatment of Novel Coronavirus Pneumonia (NCP),Recruiting,NA,NA,2000,Anticipated,"Wuhan Union Hospital, China",,NA,NA,NA,FALSE,NA,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-01T09:23:13Z,2020-04-01T09:23:13Z,4278041,NCT04283396,Coronavirus Infections,coronavirus infections,Combination Product,systemic treatment,"Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin",1,Recruiting,Union hospital,Wuhan,Hubei,430000,China,1
"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-20,NA,NA,2020-03-23,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-23,2020-03-24,Actual,"March 25, 2020",Anticipated,2020-03-25,March 2020,2020-03-31,"July 20, 2020",Anticipated,2020-07-20,"May 15, 2020",Anticipated,2020-05-15,NA,Observational,COVID-19,,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress","Investigation of Physical Activity, Quality of Life and Stress Levels of Individuals Who Live in Their Homes Isolated Because of Coronavirus (COVID-19) Disease",Not yet recruiting,NA,NA,200,Anticipated,Istanbul University-Cerrahpasa,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-04-03T09:19:55Z,2020-04-03T09:19:55Z,4856373,NCT04319211,Coronavirus Infections,coronavirus infections,Other,"Determination of physical activity, quality of life, stress levels of isolated people at home with the danger of coronavirus.","The study will include those who isolate themselves at home for fear of contracting Coronavirus disease or suspected of having it. The last three sections of the International Physical Activity Questionnaire (IPAQ) will be used to evaluate the current physical activity level of the participants. Parameters such as housework, home care and family care, rest, sports and leisure physical activities, sitting time will be evaluated. Short Form 12 (Short Form12- SF12) quality of life scale will be used to evaluate health-related quality of life. Beck Depression Scale will be applied to investigate the stress levels of the individuals participating in our study.",1,,Istanbul University Cerrahpasa,Istanbul,,,Turkey,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-03-17,NA,NA,2020-03-18,2020-03-17,2020-03-19,Actual,NA,NA,NA,NA,NA,NA,2020-03-18,2020-03-20,Actual,"March 17, 2020",Actual,2020-03-17,March 2020,2020-03-31,"January 1, 2023",Anticipated,2023-01-01,"January 1, 2021",Anticipated,2021-01-01,NA,Observational,CovidTox,,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Recruiting,NA,NA,1000,Anticipated,Groupe Hospitalier Pitie-Salpetriere,,NA,1,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,No individual data is available per se. They need to be retrieved from the World Health Organization.,2020-04-01T09:19:14Z,2020-04-01T09:19:14Z,4274060,NCT04314817,Coronavirus Infections,coronavirus infections,Drug,Any drug used to treat Covid-19,"lopinavir/ritonavir, remdesivir, interferon beta-1a, chloroquine and/or azithromycin. This list may be amended at a further date.",1,Recruiting,AP-HP Assistance Publique Hopitaux de Paris,Paris,,,France,1
"ClinicalTrials.gov processed this data on March 31, 2020",2020-02-15,NA,NA,2020-02-20,2020-02-19,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-02-20,2020-02-24,Actual,"January 20, 2020",Actual,2020-01-20,February 2020,2020-02-29,"February 28, 2021",Anticipated,2021-02-28,"January 31, 2021",Anticipated,2021-01-31,NA,Observational,NA,,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Investigation on Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection in Isolation Unit,Recruiting,NA,NA,100,Anticipated,"Third Affiliated Hospital, Sun Yat-Sen University",,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-04-01T09:23:39Z,2020-04-01T09:23:39Z,4278533,NCT04279782,Coronavirus Infections,coronavirus infections,Other,Comprehensive treatment,"Comprehensive treatment includes antiviral therapy, antibiotics therapy, symptomatic treatment, supportive therapy.",1,Recruiting,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,510630,China,1
"ClinicalTrials.gov processed this data on April 22, 2020",2020-03-23,NA,NA,2020-04-09,2020-03-23,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-13,Actual,"March 24, 2020",Actual,2020-03-24,April 2020,2020-04-30,"August 30, 2020",Anticipated,2020-08-30,"June 30, 2020",Anticipated,2020-06-30,NA,Observational,B-DT-COV2,,Biomarkers for Identification of COVID-19 Infection,Biomarkers Identification for Diagnosis and Treatment of SARS-COV-2 Infection,Recruiting,NA,NA,110,Anticipated,University of Catanzaro,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-04-23T09:15:27Z,2020-04-23T09:15:27Z,5087130,NCT04322513,Coronavirus Infections,coronavirus infections,Diagnostic Test,Biomarkers expression,Evaluation in biomarkers expression between 2 groups,1,Recruiting,Luca Gallelli,Catanzaro,,88100,Italy,1
"ClinicalTrials.gov processed this data on April 02, 2020",2020-03-20,NA,NA,2020-03-23,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-23,2020-03-24,Actual,March 2020,Anticipated,2020-03-31,March 2020,2020-03-31,April 2022,Anticipated,2022-04-30,March 2022,Anticipated,2022-03-31,NA,Observational,COVIDSOT,,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,Not yet recruiting,NA,NA,50,Anticipated,FundaciÃ³n PÃºblica Andaluza para la gestiÃ³n de la InvestigaciÃ³n en Sevilla,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      -  Biochemical analysis

        -  Hemogram

        -  Microbiological testing will be made: blood culture, pleural liquid culture, gram stain
           and culture of sputum, detection of pneumococcus and Legionella pneumophila antigen in
           urine, in cases of pneumonia.

        -  Nasopharyngeal swabs
    ",One year after the initiation of the study,Spanish Network for Research in Infectious Disease (REIPI) and Group for the Study of Infection in Transplantation and the Immunocompromised Host (GESITRA-IC),NA,Yes,Planning for the study will be shared with potential sites pertaining to Spanish Network for Research in Infectious Disease (REIPI) and Group for the Study of Infection in Transplantation and the Immunocompromised Host (GESITRA-IC) for participation. IPD is not foreseen out of this groups due to the specific characteristics of patients and sites to be candidates for study participation.,2020-04-03T09:19:56Z,2020-04-03T09:19:56Z,4856377,NCT04319172,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"ClinicalTrials.gov processed this data on April 10, 2020",2020-03-25,NA,NA,2020-03-31,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-01,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"March 27, 2021",Anticipated,2021-03-27,NA,Observational,CORIMUNO-19,,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Recruiting,NA,NA,1000,Anticipated,Assistance Publique - HÃ´pitaux de Paris,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-04-11T09:14:11Z,2020-04-11T09:14:11Z,4953572,NCT04324047,Coronavirus Infections,coronavirus infections,NA,NA,NA,NA,Recruiting|Recruiting|Recruiting,Kremlin Bictre APHP|Cochin Aphp|Hegp Aphp,Le Kremlin-BicÃªtre|Paris|Paris,Ile De France|Ile De France|Ile De France,||,France|France|France,3
